18/08/09

All countries deserve equal access to pandemic vaccines

Preparing a flu vaccine Copyright: Jim Gathany / CDC

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>All countries deserve equal access to pandemic vaccines</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><span>Rich nations and drug manufacturers must help ensure that all populations, including the poor, have equal access to swine flu vaccinations, says Tadataka Yamada of the Bill and Melinda Gates Foundation.</span></p>
<p><span>Yamada and his colleagues have developed a set of principles to "guide the global allocation of pandemic vaccine". </span></p>
<p><span>These include using tiered pricing and boosting donations to make vaccines more accessible to developing countries, and providing resources and technical assistance to bolster mechanisms for distributing vaccines. Yamada says that using adjuvants to enhance the action of vaccines could also reduce the dose needed by up to 75 per cent, and he calls on drug regulators to speed up the approval process. </span></p>
<p><span>Drug manufacturers must not commit all their capacity to countries that can pay the most, or reserve supplies for their own countries, says Yamada. All nations deserve equal access to vaccines, regardless of their ability to pay for them. In return, the manufacturers should be protected against liability for potential adverse reactions to their vaccines, he adds. </span></p>
<p><span><a target="_blank" href="http://content.nejm.org/cgi/content/full/NEJMp0906972?query=TOC" rel="noopener noreferrer">Link to full article in <em>The New England Journal of Medicine</em></a></span></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/opinions/all-countries-deserve-equal-access-to-pandemic-vac/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/opinions/all-countries-deserve-equal-access-to-pandemic-vac/",null,true])
</script>
</div>

Rich nations and drug manufacturers must help ensure that all populations, including the poor, have equal access to swine flu vaccinations, says Tadataka Yamada of the Bill and Melinda Gates Foundation.

Yamada and his colleagues have developed a set of principles to "guide the global allocation of pandemic vaccine".

These include using tiered pricing and boosting donations to make vaccines more accessible to developing countries, and providing resources and technical assistance to bolster mechanisms for distributing vaccines. Yamada says that using adjuvants to enhance the action of vaccines could also reduce the dose needed by up to 75 per cent, and he calls on drug regulators to speed up the approval process.

Drug manufacturers must not commit all their capacity to countries that can pay the most, or reserve supplies for their own countries, says Yamada. All nations deserve equal access to vaccines, regardless of their ability to pay for them. In return, the manufacturers should be protected against liability for potential adverse reactions to their vaccines, he adds.

Link to full article in The New England Journal of Medicine